| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 18 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 18 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 18 |
| 3 | PANTOPRAZOLE | 18 |
| 4 | PACLITAXEL | 16 |
| 5 | ALEMTUZUMAB | 15 |
| 6 | DOXORUBICIN | 14 |
| 7 | METHOTREXATE SODIUM | 14 |
| 8 | CISPLATIN | 13 |
| 9 | PREDNISONE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2 | 0.0032 |
| 1 | PYRIMETHAMINE | 4 | 0.0031 |
| 2 | RADIUM RA 223 DICHLORIDE | 6 | 0.0012 |
| 3 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 5 | 0.0011 |
| 4 | PRALSETINIB | 2 | 0.0011 |
| 5 | ERIBULIN MESYLATE | 3 | 0.0008 |
| 6 | ALEMTUZUMAB | 15 | 0.0008 |
| 7 | MESNA INJECTION | 6 | 0.0007 |
| 8 | MESNA | 6 | 0.0007 |
| 9 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 36 |
| 1 | Alkylating Drug [EPC] | 30 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| 3 | Platinum-based Drug [EPC] | 22 |
| 4 | Microtubule Inhibitor [EPC] | 20 |
| 5 | Loop Diuretic [EPC] | 19 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 15 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 15 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 4 | 0.0031 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 15 | 0.0008 |
| 2 | Sulfonamide Antibacterial [EPC] | 2 | 0.0005 |
| 3 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 5 | Influenza A M2 Protein Inhibitor [EPC] | 2 | 0.0001 |
| 6 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 12 | 0.0001 |
| 7 | Alkylating Drug [EPC] | 30 | 0.0001 |
| 8 | Microtubule Inhibitor [EPC] | 20 | 0.0001 |
| 9 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |